Clinical Trial Detail

NCT ID NCT01941927
Title Trametinib With GSK2141795 in BRAF Wild-type Melanoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Adil Daud
Indications

melanoma

Therapies

Trametinib + Uprosertib

Age Groups: adult senior

Additional content available in CKB BOOST